Purchase Order HT940625P0016
Award Date
4/15/25
Potential Completion Date
3/30/30
Potential Value
$1.3M
Federal Agency
Defense Health Agency
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6630 - Chemical Analysis Instruments
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Langley AFB, VA 23665, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for a chemistry analyzer from Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The $9,280.72 firm fixed-price purchase order was awarded on October 1, 2021 by the Defense Health Agency, with an ultimate completion date of September 30, 2026. The contract does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostic products, laboratory instruments, and associated...
This is a $311,081.10 firm-fixed-price purchase order contract awarded by the Veterans Integrated Service Network 9 of the U.S. Department of Veterans Affairs to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostic products and laboratory instruments. The contract is for the provision of an ANALYZER and has an ultimate completion date of April 19, 2027. The award is not associated with a set-aside program. Roche Diagnostics holds multiple Indefinite...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $1,152,215.10 contract is for a "Cost Per Test Lab" requirement and does not have a set-aside designation. Roche Diagnostics has previously...
This is a firm fixed price delivery order contract awarded by the Defense Health Agency to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $870,113.40, is for the provision of clinical chemical analyzers and reagents. The contract has no set-aside designation, indicating it was competed openly. Roche Diagnostics Corporation holds multiple...
This firm fixed-price purchase order was awarded by the Defense Health Agency to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, with a potential value of $230,895.88, is for the provision of immunoassay services on a per-reportable-result basis, with a completion date of April 30, 2022. Roche Diagnostics has a history of providing critical care analyzers,...
This is a $787,038.78 firm fixed-price delivery order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract, which has no set-aside designation, provides for the delivery of Roche's medical diagnostic technologies, including laboratory equipment, testing systems, reagents, and clinical testing services, to support...
This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract, valued at $330,646.79, is for the delivery of controls, reagents, and consumables. This award is a call order under a Blanket Purchase Agreement (BPA) established by DHA, which has a $37 million ceiling and provides immunochemistry and clinical chemistry testing...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, laboratory instruments, and medical products. The $262,962.36 contract is for the supply of reagents and consumables to support the government-owned Roche b221 blood gas analyzers at Madigan Army Medical Center, Joint Base Lewis-McChord in Washington. The contract has a period of performance through September 30, 2025. This...
This is a delivery order contract awarded by the Defense Health Agency (DHA), a defense agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and associated products and services. The $341,575.26 firm-fixed-price contract provides reagents under the Critical Analyzers, Laboratory GSA Schedule contract (FSS-66-III). The contract has an ultimate completion date of March 31, 2025. Roche Diagnostics has a history of providing medical equipment,...
This is a firm fixed-price delivery order issued by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $200,000.00 contract is for Chemistry Cost per Reportable Result and is not set aside. The contract will run through June 30, 2024 and is placed against Roche's existing General Services...